Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study
about
Antiplatelet agents for chronic kidney diseaseAntiplatelet agents for chronic kidney diseaseThe Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modificationsPrimary patency rate of native AV fistula: long term follow up.Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network.Administration of a High-Dose Erythropoietin-Stimulating Agent in Hemodialysis Patients is Associated with Late Arteriovenous Fistula Failure.Combined use of heparin and anisodamine reduces the risk of early thrombosis in native arteriovenous fistula.Effect of exercise performed during hemodialysis: strength versus aerobic.Maturation of arteriovenous fistula: Analysis of key factors.
P2860
Q24197614-68D636CA-D0DA-4F4B-B38D-5068D41B9EB4Q24200752-D600F8DB-06E4-4A7A-B75F-AE29217F7282Q35676161-73D140B2-03F2-4170-8C4F-C8227D2C2B95Q35929583-21F4F03C-34DB-4A7D-BDF4-9EA01E112EA9Q36443751-C971D852-D651-4F0C-BE8F-3423275C0D49Q37503167-18CB49F1-14B7-4C45-83C2-6F82EDABC2ADQ42241135-38A433BE-1DAC-4B56-B7B1-1EE299EFDBA5Q44050196-A968F62B-33AA-4EB7-A26E-AC0D1ACE4065Q46510777-E3C06AE0-12E9-4583-BDE0-BF2A1F358309Q47142994-E63C2CC8-A0AA-4E32-8B4C-92BE1B8DD587
P2860
Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Preventing AVF thrombosis: the ...... REnal Disease (FAVOURED) study
@ast
Preventing AVF thrombosis: the ...... REnal Disease (FAVOURED) study
@en
type
label
Preventing AVF thrombosis: the ...... REnal Disease (FAVOURED) study
@ast
Preventing AVF thrombosis: the ...... REnal Disease (FAVOURED) study
@en
prefLabel
Preventing AVF thrombosis: the ...... REnal Disease (FAVOURED) study
@ast
Preventing AVF thrombosis: the ...... REnal Disease (FAVOURED) study
@en
P2093
P2860
P50
P356
P1433
P1476
Preventing AVF thrombosis: the ...... REnal Disease (FAVOURED) study
@en
P2093
Amanda Robertson
Gursharan Dogra
Kevan Polkinghorne
Melissa Starfield
Peta-Anne Paul-Brent
Peter Kerr
Stephane Heritier
Trevor Mori
P2860
P2888
P356
10.1186/1471-2369-10-1
P577
2009-01-21T00:00:00Z
P5875
P6179
1048757183